【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Raynauds Disease Overview 7
Therapeutics Development 8
Pipeline Products for Raynauds Disease – Overview 8
Pipeline Products for Raynauds Disease – Comparative Analysis 9
Raynauds Disease – Therapeutics under Development by Companies 10
Raynauds Disease – Therapeutics under Investigation by Universities/Institutes 11
Raynauds Disease – Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Raynauds Disease – Products under Development by Companies 15
Raynauds Disease – Products under Investigation by Universities/Institutes 16
Raynauds Disease – Companies Involved in Therapeutics Development 17
Allergan, Inc. 17
Apricus Biosciences, Inc. 18
Azevan Pharmaceuticals, Inc. 19
Bayer AG 20
Human Stem Cells Institute 21
Mezzion Pharma Co. Ltd. 22
Nippon Shinyaku Co., Ltd. 23
Teva Pharmaceutical Industries Limited 24
Raynauds Disease – Therapeutics Assessment 25
Assessment by Monotherapy Products 25
Assessment by Target 26
Assessment by Mechanism of Action 28
Assessment by Route of Administration 30
Assessment by Molecule Type 32
Drug Profiles 34
alprostadil – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
ELS-140 – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Disease and Central Nervous System Disorders – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
MDT-012 – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
onabotulinumtoxin A – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
riociguat – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
selexipag – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Small Molecules to Inhibit Alpha 2 Adrenergic Receptor for Raynauds Disease – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
SRX-251 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
udenafil – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Raynauds Disease – Recent Pipeline Updates 51
Raynauds Disease – Dormant Projects 66
Raynauds Disease – Discontinued Products 67
Raynauds Disease – Product Development Milestones 68
Featured News & Press Releases 68
Jan 27, 2015: Apricus Biosciences Announces Issuance of U.S. Patent for RayVa 68
Dec 04, 2014: Apricus Biosciences Announces First Patient Enrolled In Phase 2a Clinical Trial For RayVa In Patients With Raynaud’s Phenomenon 68
Oct 13, 2014: Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa 69
Oct 01, 2014: Apricus Biosciences to Present at the 13th Annual BIO Investor Forum 70
May 12, 2014: Apricus Biosciences Receives FDA Clearance to Begin Clinical Trial of RayVa for Secondary Raynaud’s Phenomenon 70
May 31, 2011: Apricus Bio Receives Israeli Patent For RayVa For Raynaud’s Phenomenon 71
Apr 13, 2011: Apricus Bio Files For Orphan Drug Designation For RayVa 71
Sep 22, 2010: FDA Guides Apricus Bio On RayVa’s Approvability For Raynaud’s Syndrome Secondary To Scleroderma 72
Appendix 73
Methodology 73
Coverage 73
Secondary Research 73
Primary Research 73
Expert Panel Validation 73
Contact Us 73
Disclaimer 74
【レポート販売概要】
■ タイトル:レイノー病(Raynauds Disease):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Raynauds Disease - Pipeline Review, H1 2015
■ 発行日:2015年3月19日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6430IDB
■ 調査対象地域:グローバル
- 高血圧薬の世界市場2019-2023About this market Patients with hypertension are generally treated with drugs that can reduce blood volume (reducing central venous pressure and cardiac output), reduce systemic vascular resistance, and reduce cardiac output by depressing heart rate and stroke volume. For instance, diuretic drugs decrease the blood volume by increasing urine output by the kidney. Similarly, vasodilator drugs dilat …
- セノスフェアの世界市場予測(~2022年):灰色セノスフェア、白色セノスフェア“The cenospheres market is projected to reach USD 689.2 million by 2022”The global cenospheres market was valued at USD 346.8 million in 2016 and is projected to reach USD 689.2 million by 2022, at a CAGR of 12.16% from 2017 to 2022. The growing demand from end-use industries, such as paints & coatings, refractory, construction, and oil & gas is expected to drive the market in near future. However …
- ニューラルネットワークソフトウェアの世界市場予測(~2021):種類別(データマイニング&データアーカイブ、分析ソフトウェア、最適化ソフトウェア、可視化ソフトウェア)、産業別、地域別“Increasing demand for predicting solutions and analytical tools is expected to drive the neural network software market”MarketsandMarkets forecasts the global neural network software market to expand from USD 7.17 billion in 2016 to USD 22.55 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 33.2%. The market is escalating rapidly owing to rising digitization trend and the surplus amoun …
- おむつの世界市場:幼児用おむつ、大人用おむつAbout Diaper Market The global baby diaper market was dominated by the disposable diapers segment in 2015, followed by the training diapers, cloth diapers, swim pants, and biodegradable diaper segments. While baby diapers can be used by all babies, adult diapers are generally used by people aged above 55 years who suffer from problems such as incontinence, diarrhea, dementia, and physical disabili …
- 中小企業向け金融の世界市場2015-2019Micro, small and medium enterprises (MSME) are one of the key economic segments that drives the growth of the GDP by boosting the manufacturing and exports of the economy. The adoption of improved risk management practices by the financial institutions is one of the key drivers for the growth of this market. Technavio’s research analyst predicts the MSME financing market to grow at a rate of 19% d …
- 炭素管理ソフトウェアの世界市場2015-2019About Carbon Management Software Carbon management software is a tool that aids organizations in planning and implementing their carbon management strategies. Carbon management tools help organizations accurately measure and reduce their carbon footprints, meet their objectives of corporate sustainability, and fulfill government mandates. The increasing amount of GHG emissions is a major concern f …
- アミラーゼの世界市場2018-2022110 pages, November 2018 About this market The growing demand for processed foods has been one of the key driving factor in the market due to change in consumer behavior and the growth of the processed- food industry. The high demand for convenience foods and fast food exerts a positive influence on the requirement for food enzyme that include amylase. Further, the demand for processed food also h …
- リッチコミュニケーションサービス(RCS)の市場機会と予測2013-2018(Rich Communications Services (RCS): Market Opportunities and Forecast 2013 – 2018)RCS represents the first LTE-enabled value-added service (VAS) application for carriers. There are some pre-Voice over LTE (VoLTE) options, and a migration path for RCS that is pre-IP Multimedia Subsystem (IMS), but we ultimately see RCS adding most value with ubiquitous VoLTE coverage and IMS integration. We also see significant value open via API integration for various VAS applications focused …
- POSレシートプリンタの世界市場2016-2020About POS Receipt Printer A POS receipt printer is primarily used to print and encode receipts at retail stores and hotel and restaurants chains. There are two main types of POS receipt printers in the market — impact and thermal. The revenue of the global POS receipt printer market is expected to grow at a CAGR of 8.64% during 2015-2020. Technavio’s analysts forecast the global point-of-sale (POS …
- 美容レーザーの世界市場予測:CO2レーザー、Er:YAGレーザー、ダイオードレーザー、Nd:YAGレーザー、アレキサンドライトレーザー、パルス色素レーザーThe cosmetic lasers market is projected to reach USD 1,132.7 Million by 2021 from USD 697.6 Million in 2016, growing at a CAGR of 10.2% during the forecast period. Increasing preference for noninvasive cosmetic procedures, increasing disposable income, technological advancements, and rising medical tourism are the major drivers of the aesthetic lasers market. However, lack of reimbursement will re …
- 防爆電気モーター・アクチュエーターの世界市場2019-2023About this market Growing need for customized and compact explosion-proof motors to drive growth in the market. Vendors are constantly trying to differentiate their products. The stringent regulations norms regarding the equipment safety in harsh environments have prompted the vendors to constantly improve their explosion-proof motors products. The growing variations of applications, varying clima …
- オーソバイオロジクスの世界市場予測(~2022年):関節内補充療法、合成オーソバイオロジクス、DBM、BMP、PRP、BMAC、同種移植片“The orthobiologics market projected to grow at a CAGR of 5.4%.”The global orthobiologics market is projected to reach USD 6.06 billion by 2022 from USD 4.66 billion in 2017, at a CAGR of 5.4%. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing agi …
- スマートソーラーの世界市場:ネットワーク監視、メーターデータ管理、アナリティクス、SCADA、リモート計量、資産管理、停電管理MarketsandMarkets forecast the smart solar market size to grow from USD 6.47 Billion in 2015 to USD 13.26 Billion by 2020, at a compound annual growth rate (CAGR) of 15.4%. Strict mandates of regulatory bodies has led the organizations to upgrade to the upcoming technological solutions, such as analytics and real-time monitoring. This acts as a primary driving factor for the smart solar market as …
- 世界の海洋掘削市場The growing demand for energy coupled with increasing investment in offshore exploration activities will drive the global market to $121.1 billion by 2018, growing at a CAGR of 10.6% from 2013 to 2018. Asia-Pacific, with its thriving economies and rapidly increasing energy consumption, is expected to experience the highest revenue growth during the next five years. The factors that drive growth in …
- メキシコの心臓律動管理(CRM)装置市場見通しMexico Cardiac Rhythm Management (CRM) Procedures Outlook to 2021 Summary GlobalData’s new report, "Mexico Cardiac Rhythm Management (CRM) Procedures Outlook to 2021", provides key procedures data on the Mexico Cardiac Rhythm Management (CRM) Procedures. The report provides procedure volumes within market segments - Implantable Loop Recorder (ILR) Procedures, Cardiac Resynchronisation Therapy (CRT …